Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

被引：0
|
作者：
Pirker, R
Jaeger, U
Pohl, G
Stranzl, T
Simonitsch, I
Kaider, A
Skrabs, C
Filipits, M
机构：
[1] Univ Vienna, Dept Internal Med 1, Vienna, Austria
[2] Univ Vienna, Inst Clin Pathol, Vienna, Austria
[3] Univ Vienna, Dept Med Comp Sci, Vienna, Austria
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
528
引用
收藏
页码：126A / 126A
页数：1
相关论文
共 50 条
  • [1] Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma
    Filipits, M
    Jaeger, U
    Pohl, G
    Stranzl, T
    Simonitsch, I
    Kaider, A
    Skrabs, C
    Pirker, R
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 729 - 733
  • [2] Prognostic significance of the cyclin D3 and the Ki-67 expression for predicting clinical outcome in diffuse large B-cell lymphoma
    Shin, HJ
    Chung, J
    Park, DY
    Cho, GJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 611S - 611S
  • [3] Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth Evidence for redundancy with cyclin E
    Gumina, Maria R.
    Xu, Chenjia
    Chiles, Thomas C.
    CELL CYCLE, 2010, 9 (04) : 820 - 828
  • [4] Potential prognostic and predictive factors in diffuse large B-cell lymphoma
    Flodr, P.
    Latalova, P.
    Tichy, M.
    Kubova, Z.
    Papajik, T.
    Svachova, M.
    Radova, L.
    Jarosova, M.
    VIRCHOWS ARCHIV, 2014, 465 : S277 - S277
  • [5] Splenic diffuse red pulp small B-cell lymphoma with cyclin D3 expression
    Ozkaya, Neval
    Jaffe, Elaine S.
    BLOOD, 2022, 140 (07) : 793 - 793
  • [6] Fostamatinib for the treatment of diffuse large B-cell lymphoma.
    Arkenau, Hendrik-Tobias
    Patrikidou, Anna
    Flinn, Ian
    Hylton, Jonas C.
    Tong, Sandra
    Ardeshna, Kirit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Unusual presentation of diffuse large B-cell lymphoma.
    Persing, B.
    Herrin, V.
    Elkins, S.
    Files, J.
    Bigelow, C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S268 - S268
  • [8] Expression of mTOR in diffuse large B-cell lymphoma.
    Gopaluni, Srivalli
    Vajpayee, Neerja
    Newman, Nancy
    Thakral, Charu
    Husain, Juhi
    Gajra, Ajeet
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Immunohistochemical markers in the prognostic model for survival of patients with diffuse large B-cell lymphoma.
    Kobilov, Odiljon
    Kamishov, Sergey
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Cyclin D1-positive diffuse large B-cell lymphoma
    Rodriguez-Justo, M.
    Huang, Y.
    Ye, H.
    Liu, H.
    Chuang, S-S
    Munson, P.
    Prada-Puentes, C.
    Kim, I.
    Du, M-Q
    Bacon, C. M.
    HISTOPATHOLOGY, 2008, 52 (07) : 900 - 903
12345